CY1178A - 21-halogenopregnane compounds - Google Patents
21-halogenopregnane compoundsInfo
- Publication number
- CY1178A CY1178A CY1178A CY117877A CY1178A CY 1178 A CY1178 A CY 1178A CY 1178 A CY1178 A CY 1178A CY 117877 A CY117877 A CY 117877A CY 1178 A CY1178 A CY 1178A
- Authority
- CY
- Cyprus
- Prior art keywords
- halogenopregnane
- compounds
- halogenopregnane compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
- C07J7/008—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
- C07J7/0085—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 by an halogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
- C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
- C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
- C07J5/0069—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
- C07J5/0076—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
- C07J71/001—Oxiranes
- C07J71/0015—Oxiranes at position 9(11)
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pain & Pain Management (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Rheumatology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| LU75903A LU75903A1 (fr) | 1976-09-29 | 1976-09-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1178A true CY1178A (en) | 1983-06-10 |
Family
ID=19728370
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY1178A CY1178A (en) | 1976-09-29 | 1977-09-27 | 21-halogenopregnane compounds |
Country Status (24)
| Country | Link |
|---|---|
| JP (1) | JPS5356652A (fr) |
| AT (3) | AT363197B (fr) |
| AU (1) | AU514200B2 (fr) |
| BE (1) | BE859120A (fr) |
| CA (1) | CA1101410A (fr) |
| CH (9) | CH624967A5 (fr) |
| CY (1) | CY1178A (fr) |
| DD (1) | DD133150A5 (fr) |
| DE (1) | DE2743069C2 (fr) |
| DK (1) | DK146017C (fr) |
| ES (1) | ES462763A1 (fr) |
| FR (1) | FR2366311A1 (fr) |
| GB (1) | GB1563638A (fr) |
| HK (1) | HK16683A (fr) |
| HU (1) | HU175218B (fr) |
| IE (1) | IE46047B1 (fr) |
| IL (1) | IL53012A (fr) |
| KE (1) | KE3258A (fr) |
| LU (1) | LU75903A1 (fr) |
| MY (1) | MY8400092A (fr) |
| NL (1) | NL7710089A (fr) |
| SE (1) | SE436751B (fr) |
| SG (1) | SG3383G (fr) |
| ZA (1) | ZA775800B (fr) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL187577C (nl) * | 1978-04-05 | 1991-11-18 | Sibla Srl | 3-acetoxy-9beta,11beta-epoxy-pregna-1,3,5-trienen, werkwijze voor de bereiding daarvan en werkwijze voor de bereiding van 6alfa-halogeen-pregna-1,4-dieen-3-onen. |
| DE3227312A1 (de) * | 1982-07-19 | 1984-01-19 | Schering AG, 1000 Berlin und 4709 Bergkamen | Neue 6,16-dimethylkortikoide, ihre herstellung und verwendung |
| EP0523132A1 (fr) * | 1990-03-27 | 1993-01-20 | Schering Corporation | PROCEDE DE DESHYDRATATION DE 9$g(a)-HYDROXY STEROIDES |
| US5972922A (en) * | 1990-06-11 | 1999-10-26 | Alcon Laboratories, Inc. | Steroids which inhibit angiogenesis |
| CA2473471A1 (fr) | 2001-11-29 | 2003-06-12 | Taro Pharmaceuticals U.S.A., Inc. | Procede relatif a l'elaboration de 6-alpha-fluorocorticosteroides |
| US8809307B2 (en) | 2010-11-22 | 2014-08-19 | Dow Pharmaceutical Sciences, Inc. | Pharmaceutical formulations containing corticosteroids for topical administration |
| US11957753B2 (en) | 2010-11-22 | 2024-04-16 | Bausch Health Ireland Limited | Pharmaceutical formulations containing corticosteroids for topical administration |
| AU2016279801B2 (en) | 2015-06-18 | 2021-09-09 | Valeant Pharmaceuticals North America | Topical compositions comprising a corticosteroid and a retinoid for treating psoriasis |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB898292A (en) * | 1959-03-18 | 1962-06-06 | Upjohn Co | Improvements in or relating to steroids and the manufacture thereof |
| US3644340A (en) * | 1970-03-19 | 1972-02-22 | Syntex Corp | Preparation of 21-chloro steroids |
| US3992422A (en) * | 1975-08-14 | 1976-11-16 | Schering Corporation | Process for the preparation of 21-halogeno-21-desoxy-17α-acyloxy-20-keto-pregnenes |
-
1976
- 1976-09-29 LU LU75903A patent/LU75903A1/xx unknown
- 1976-12-09 CH CH1549976A patent/CH624967A5/de not_active IP Right Cessation
-
1977
- 1977-06-08 SE SE7706673A patent/SE436751B/xx not_active IP Right Cessation
- 1977-06-09 DK DK256977A patent/DK146017C/da not_active IP Right Cessation
- 1977-09-14 NL NL7710089A patent/NL7710089A/xx not_active Application Discontinuation
- 1977-09-24 DE DE2743069A patent/DE2743069C2/de not_active Expired
- 1977-09-26 CH CH1172177A patent/CH632279A5/de not_active IP Right Cessation
- 1977-09-27 AU AU29148/77A patent/AU514200B2/en not_active Expired
- 1977-09-27 FR FR7729043A patent/FR2366311A1/fr active Granted
- 1977-09-27 DD DD7700201226A patent/DD133150A5/xx unknown
- 1977-09-27 CA CA287,560A patent/CA1101410A/fr not_active Expired
- 1977-09-27 CY CY1178A patent/CY1178A/xx unknown
- 1977-09-27 GB GB40131/77A patent/GB1563638A/en not_active Expired
- 1977-09-28 HU HU77CI1774A patent/HU175218B/hu unknown
- 1977-09-28 IL IL53012A patent/IL53012A/xx unknown
- 1977-09-28 AT AT0691077A patent/AT363197B/de not_active IP Right Cessation
- 1977-09-28 BE BE181243A patent/BE859120A/fr not_active IP Right Cessation
- 1977-09-28 IE IE1979/77A patent/IE46047B1/en not_active IP Right Cessation
- 1977-09-28 ZA ZA00775800A patent/ZA775800B/xx unknown
- 1977-09-29 JP JP11619377A patent/JPS5356652A/ja active Granted
- 1977-09-29 ES ES462763A patent/ES462763A1/es not_active Expired
-
1979
- 1979-02-28 AT AT0151379A patent/AT363203B/de not_active IP Right Cessation
- 1979-02-28 AT AT0151279A patent/AT363202B/de not_active IP Right Cessation
-
1980
- 1980-11-18 CH CH853780A patent/CH625808A5/de not_active IP Right Cessation
- 1980-11-18 CH CH853880A patent/CH625809A5/de not_active IP Right Cessation
- 1980-11-18 CH CH853980A patent/CH625810A5/de not_active IP Right Cessation
-
1981
- 1981-10-26 CH CH683081A patent/CH631998A5/de not_active IP Right Cessation
- 1981-10-26 CH CH683181A patent/CH631999A5/de not_active IP Right Cessation
- 1981-10-26 CH CH683281A patent/CH632000A5/de not_active IP Right Cessation
-
1982
- 1982-01-06 CH CH4682A patent/CH632521A5/de not_active IP Right Cessation
-
1983
- 1983-01-20 SG SG33/83A patent/SG3383G/en unknown
- 1983-01-21 KE KE3258A patent/KE3258A/xx unknown
- 1983-05-19 HK HK166/83A patent/HK16683A/xx not_active IP Right Cessation
-
1984
- 1984-12-30 MY MY92/84A patent/MY8400092A/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL48824A0 (en) | Thc-type compounds | |
| JPS52151348A (en) | Compound | |
| JPS5363424A (en) | Bitumious compound | |
| JPS52125197A (en) | Transshexahydroopyridooindole compound | |
| JPS5297994A (en) | Betaalactummcontaining compounds | |
| JPS5317639A (en) | Hexakisazo compounds | |
| JPS5353618A (en) | Nnsubstituted biscarbamoylsulfide compound | |
| GB1539364A (en) | 11-deoxy-11-oxaprostaglandin compounds | |
| JPS5325537A (en) | Compound | |
| JPS5295689A (en) | Betaalactummcontaining compound | |
| JPS5359686A (en) | Compound | |
| JPS5293772A (en) | Indolinospiropyran compound | |
| HK16683A (en) | 21-halogenopregnane compounds | |
| JPS5323995A (en) | Antiibacterial compound | |
| JPS52156899A (en) | Compound | |
| JPS5321222A (en) | Bissbenzoxazolyl compound | |
| JPS52111590A (en) | Novel cephalospoline compounds | |
| JPS5353692A (en) | Antiiworm compound | |
| JPS52102227A (en) | Haloalkylphosphate compounds | |
| ZA772175B (en) | Oxothia compounds | |
| JPS5285216A (en) | Azamethineemetal complex compounds | |
| JPS5353693A (en) | Antiiworm compound | |
| JPS5297990A (en) | Cephalospoline compounds | |
| JPS52125158A (en) | Oxothia compound | |
| JPS52100491A (en) | Cephalospoline compounds |